Olopatadine HCL 0.1% Ophthalmic Solution

Notice ID:SPE2D222R0117

Solicitation SPE2D2-22-R-0117

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY (DLA) DLA TROOP SUPPORT
  PSC   6505 DRUGS AND BIOLOGICALS
LOCATION: Not Given
Primary Contact
Phyllis Daraio
215-***-7941
Alt Contact
Jason Wray
215-***-0614


Data sourced from SAM.gov. View Official Posting »

Olopatadine HCL 0.1% Ophthalmic Solution

Notice ID:SPE2D222R0117

The Defense Logistics Agency is planning a national requirements contract for Olopatadine HCL 0.1% Ophthalmic Solution. It will be a firm-fixed price contract with a one-year base period and four one-year option periods. The contract will establish a national supply source for several federal agencies. The projected solicitation date is June 2022, but the agency reserves the right to issue it before or after that date. The solicitation will be posted to the DLA Bid Board System and SAM.gov.

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY (DLA) DLA TROOP SUPPORT
  PSC   6505 DRUGS AND BIOLOGICALS
LOCATION: Not Given
Primary Contact
Phyllis Daraio
215-***-7941
Alt Contact
Jason Wray
215-***-0614

Links (0)

Attachments (0)


Data sourced from SAM.gov. View Official Posting »